Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Added

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate readOnlyHint, openWorldHint, idempotentHint, destructiveHint. The description adds valuable behavioral context: specific data sources (SEC EDGAR/XBRL for companies, FAERS for drugs), handling of off-calendar fiscal years, sorting by primary metric, and return of citation URIs. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is slightly long but front-loaded with trigger phrases that help an agent quickly identify when to use it. Every sentence adds essential information; can be justified despite length.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given no output schema, the description compensates by detailing return format (paired data, citation URIs, sorted by primary metric) and data sources. It covers both entity types, special cases (off-calendar fiscal years), and limitations (2-5 entities). Complete for the tool's complexity.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so baseline is 3. The description adds meaning by explaining the data pulled for each type (e.g., revenue, net income for companies; adverse-event counts for drugs) and giving example inputs. This goes beyond the schema's enum and array descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool performs side-by-side comparison of 2-5 companies or drugs in one parallel call, with specific query triggers like "Compare X and Y". It differentiates between entity types and data sources, and contrasts with sequential lookups from sibling tools like entity_profile.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly advises to prefer this tool over sequential single-pack lookups when comparing entities, providing strong usage guidance. It does not detail when not to use it, but the context is clear enough for correct selection.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are essentially the same router with different output modes, and ask_pipeworx_beta is currently identical to ask_pipeworx. There is also meaningful overlap between entity_profile, compare_entities, recent_changes, validate_claim, and the USAspending profile/search tools.

Naming Consistency3/5

All names are lower_snake_case with useful prefixes like ask_, polymarket_, and usa_, which helps grouping. However, the underlying convention is mixed: some are verb+object, some are noun phrases, and some are bare verbs, so there is no uniform verb_noun pattern.

Tool Count2/5

38 tools is well beyond the heavy range, and most of them are unrelated to USAspending: Polymarket betting, npm dependency checks, AI visibility, memory storage, and meta-tools. The actual USAspending-specific surface is only about seven tools, making the server feel bloated and unfocused.

Completeness3/5

The federal-contract cluster covers award search, recipient/incumbent profiles, expiring awards, and spending by agency/category/trend, which handles the main contracting questions. Missing award-detail retrieval, grants/assistance coverage, and open-solicitation lookup, which usa_expiring_awards explicitly punts to external samgov/govcon tools.